Jenny Kobin | Investor Relations |
George Lasezkay | Chief Executive Officer |
Thomas Ciulla | Chief Medical Officer and Chief Development Officer |
Charlie Deignan | Chief Financial Officer |
Annabel Samimy | Stifel |
Yi Chen | H.C. Wainwright |
Andreas Argyrides | Wedbush |
Jon Wolleben | JMP Securities |
Zegbeh Jallah | ROTH Capital Partners |
Good day. Thank you for standing by. And welcome to the Clearside Biomedical Q3 2021 Financial Results and Corporate Update Call. At this time, all participants are in a listen-only mode. After the speakers presentation there will be a question-and-Answer session.